0
Review ? AI-assigned paper type based on the abstract. Classification may not be perfect — flag errors using the feedback button. Tier 2 ? Original research — experimental, observational, or case-control study. Direct primary evidence. Food & Water Gut & Microbiome Human Health Effects Policy & Risk Remediation Sign in to save

A critical review of microplastics toxicity and potential adverse outcome pathway in human gastrointestinal tract following oral exposure

Toxicology Letters 2023 38 citations ? Citation count from OpenAlex, updated daily. May differ slightly from the publisher's own count.
Lorna R. Jones, Stephanie Wright, Timothy W. Gant

Summary

This review uses an adverse outcome pathway framework to systematically evaluate how microplastics may cause harm in the human digestive system after being swallowed. The analysis found that while microplastics trigger recognized biological stress responses like cell death and inflammation, there are still major gaps in understanding exactly how they initiate damage at the molecular level. The authors emphasize that we need better data on both external exposure from food and water and internal exposure from particles crossing the gut lining to properly assess the health risks.

Body Systems

Microplastics (MPs) are typically produced via environmental degradation of larger plastics, where they enter the human food chain. MPs are complex materials containing chemical and physical characteristics that can potentially affect their hazard and exposure. These physical properties can be altered by environmental exposure potentially altering any risk assessment conducted on the primary material. We conducted a literature review using an Adverse Outcome Pathway (AOP)-based approach from Molecular Initiating Event (MIE) to cell effect event to identify multiple knowledge gaps that affect MPs hazard assessment. There is some convergence of key biological events but could relate to most lying along well-established biological effector pathways such as apoptosis which can respond to many MIEs. In contrast, MIEs of chemicals will be via protein interaction. As MPs may occur in the lumen of the alimentary canal for example to the mucus, therefore, not requiring translocation of MPs across the epithelial membrane. At the other end of the AOP, currently it is not possible to identify a single adverse outcome at the organ level. This work did establish a clear need to understand both external and internal exposure (resulting from translocation) and develop hazard data at both levels to inform on risk assessments.

Share this paper